NORDITROPIN (somatropin) by Novo Nordisk. Approved for recombinant human growth hormone [epc]. First approved in 2000.
Drug data last refreshed 17h ago · AI intelligence enriched 2mo ago
NORDITROPIN is a recombinant human growth hormone (somatropin) administered via injection for treatment of growth hormone deficiency and related disorders. It replaces or supplements endogenous growth hormone to promote linear growth, metabolic function, and body composition in affected patients. The drug is a cytokine-based biologic that mimics the natural hormone produced by the anterior pituitary gland.
Product approaching loss of exclusivity with moderate competitive pressure (30/100); brand team focus is shifting toward lifecycle management and differentiated formulations like FlexPro to maintain market position.
Recombinant Human Growth Hormone
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Phase 3 Clinical Trial Evaluating the Efficacy and Safety of Navepegritide and Lonapegsomatropin in Achondroplasia
A Clinical Study of Long-Term Administration of Inpegsomatropin Injection in Participants With Idiopathic Short Stature Who Have Completed Phase Ⅲ Clinical Trials
The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature
Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone Deficiency
A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin (Somatropin) Delivery and Taken up Into the Blood in Healthy Adults
Worked on NORDITROPIN at Novo Nordisk? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Novo Nordisk is hiring 1 role related to this product
Working on NORDITROPIN offers career opportunities primarily in lifecycle management, regulatory strategy, and financial stewardship as the product approaches LOE. Roles span from Director-level strategic planning to clinical and biostatistics support for label maintenance and formulation defense, with strong emphasis on financial accountability and regulatory compliance.
8 open roles linked to this drug